hers and semaglutide Hims & plans to launch $49 copy of Wegovy pill Novo Nordisk ends Hims &

They can help you monitor your progress and make changes as needed

In addition to treating type 2 diabetes, Semaglutide has also been approved for weight management in people who are overweight or obese and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol

Mol Cell Endocrinol 141 , 179186 (1998)

Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)